Answer
It is licensed for selected progressive, well-differentiated, somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours in adults that cannot be removed surgically or have spread.
Sources for this answer
- Lutathera 370 MBq/mL solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.